Cargando…

Evaluation of Clinical and Immunopathological Features of Different Infective Doses of Trypanosoma cruzi in Dogs during the Acute Phase

Infection with Trypanosoma cruzi is a major risk in Latin America, and dogs are believed to be good models for evaluating Chagas disease. Here, we evaluated the clinical and immunopathological alterations developed by mongrel dogs experimentally infected with different infective doses (2,000, 20,000...

Descripción completa

Detalles Bibliográficos
Autores principales: Quijano-Hernández, Israel A., Castro-Barcena, Alejandro, Aparicio-Burgos, Esteban, Barbosa-Mireles, Marco A., Cruz-Chan, Julio V., Vázquez-Chagoyán, Juan C., Bolio-González, Manuel E., Dumonteil, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323355/
https://www.ncbi.nlm.nih.gov/pubmed/22547991
http://dx.doi.org/10.1100/2012/635169
_version_ 1782229181028892672
author Quijano-Hernández, Israel A.
Castro-Barcena, Alejandro
Aparicio-Burgos, Esteban
Barbosa-Mireles, Marco A.
Cruz-Chan, Julio V.
Vázquez-Chagoyán, Juan C.
Bolio-González, Manuel E.
Dumonteil, Eric
author_facet Quijano-Hernández, Israel A.
Castro-Barcena, Alejandro
Aparicio-Burgos, Esteban
Barbosa-Mireles, Marco A.
Cruz-Chan, Julio V.
Vázquez-Chagoyán, Juan C.
Bolio-González, Manuel E.
Dumonteil, Eric
author_sort Quijano-Hernández, Israel A.
collection PubMed
description Infection with Trypanosoma cruzi is a major risk in Latin America, and dogs are believed to be good models for evaluating Chagas disease. Here, we evaluated the clinical and immunopathological alterations developed by mongrel dogs experimentally infected with different infective doses (2,000, 20,000, and 200,000 metacyclic trypomastigotes of Sylvio X10/4 strain kg(−1) via intraperitoneal). Clinical and electrocardiographic parameters, as well as antibody production and pathologic lesions were evaluated. All three doses of this strain of T. cruzi induced a similar pattern of infection characterized by cardiac arrhythmias and severe and diffuse myocarditis. Specific anti-T. cruzi IgG indicated seroconversion by day 14 after infection, and IgG levels increased during the period of evaluation. Mortality was observed only in dogs infected with the medium or high parasite doses, but not in the group infected with a low dose of 2,000 parasites kg(−1). Infection with a low dose of parasites provides an excellent nonlethal model to evaluate the immunopathology of the acute disease in dogs infected with the Sylvio X10/4 strain of T. cruzi.
format Online
Article
Text
id pubmed-3323355
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Scientific World Journal
record_format MEDLINE/PubMed
spelling pubmed-33233552012-04-30 Evaluation of Clinical and Immunopathological Features of Different Infective Doses of Trypanosoma cruzi in Dogs during the Acute Phase Quijano-Hernández, Israel A. Castro-Barcena, Alejandro Aparicio-Burgos, Esteban Barbosa-Mireles, Marco A. Cruz-Chan, Julio V. Vázquez-Chagoyán, Juan C. Bolio-González, Manuel E. Dumonteil, Eric ScientificWorldJournal Research Article Infection with Trypanosoma cruzi is a major risk in Latin America, and dogs are believed to be good models for evaluating Chagas disease. Here, we evaluated the clinical and immunopathological alterations developed by mongrel dogs experimentally infected with different infective doses (2,000, 20,000, and 200,000 metacyclic trypomastigotes of Sylvio X10/4 strain kg(−1) via intraperitoneal). Clinical and electrocardiographic parameters, as well as antibody production and pathologic lesions were evaluated. All three doses of this strain of T. cruzi induced a similar pattern of infection characterized by cardiac arrhythmias and severe and diffuse myocarditis. Specific anti-T. cruzi IgG indicated seroconversion by day 14 after infection, and IgG levels increased during the period of evaluation. Mortality was observed only in dogs infected with the medium or high parasite doses, but not in the group infected with a low dose of 2,000 parasites kg(−1). Infection with a low dose of parasites provides an excellent nonlethal model to evaluate the immunopathology of the acute disease in dogs infected with the Sylvio X10/4 strain of T. cruzi. The Scientific World Journal 2012-04-01 /pmc/articles/PMC3323355/ /pubmed/22547991 http://dx.doi.org/10.1100/2012/635169 Text en Copyright © 2012 Israel A. Quijano-Hernández et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Quijano-Hernández, Israel A.
Castro-Barcena, Alejandro
Aparicio-Burgos, Esteban
Barbosa-Mireles, Marco A.
Cruz-Chan, Julio V.
Vázquez-Chagoyán, Juan C.
Bolio-González, Manuel E.
Dumonteil, Eric
Evaluation of Clinical and Immunopathological Features of Different Infective Doses of Trypanosoma cruzi in Dogs during the Acute Phase
title Evaluation of Clinical and Immunopathological Features of Different Infective Doses of Trypanosoma cruzi in Dogs during the Acute Phase
title_full Evaluation of Clinical and Immunopathological Features of Different Infective Doses of Trypanosoma cruzi in Dogs during the Acute Phase
title_fullStr Evaluation of Clinical and Immunopathological Features of Different Infective Doses of Trypanosoma cruzi in Dogs during the Acute Phase
title_full_unstemmed Evaluation of Clinical and Immunopathological Features of Different Infective Doses of Trypanosoma cruzi in Dogs during the Acute Phase
title_short Evaluation of Clinical and Immunopathological Features of Different Infective Doses of Trypanosoma cruzi in Dogs during the Acute Phase
title_sort evaluation of clinical and immunopathological features of different infective doses of trypanosoma cruzi in dogs during the acute phase
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323355/
https://www.ncbi.nlm.nih.gov/pubmed/22547991
http://dx.doi.org/10.1100/2012/635169
work_keys_str_mv AT quijanohernandezisraela evaluationofclinicalandimmunopathologicalfeaturesofdifferentinfectivedosesoftrypanosomacruziindogsduringtheacutephase
AT castrobarcenaalejandro evaluationofclinicalandimmunopathologicalfeaturesofdifferentinfectivedosesoftrypanosomacruziindogsduringtheacutephase
AT aparicioburgosesteban evaluationofclinicalandimmunopathologicalfeaturesofdifferentinfectivedosesoftrypanosomacruziindogsduringtheacutephase
AT barbosamirelesmarcoa evaluationofclinicalandimmunopathologicalfeaturesofdifferentinfectivedosesoftrypanosomacruziindogsduringtheacutephase
AT cruzchanjuliov evaluationofclinicalandimmunopathologicalfeaturesofdifferentinfectivedosesoftrypanosomacruziindogsduringtheacutephase
AT vazquezchagoyanjuanc evaluationofclinicalandimmunopathologicalfeaturesofdifferentinfectivedosesoftrypanosomacruziindogsduringtheacutephase
AT boliogonzalezmanuele evaluationofclinicalandimmunopathologicalfeaturesofdifferentinfectivedosesoftrypanosomacruziindogsduringtheacutephase
AT dumonteileric evaluationofclinicalandimmunopathologicalfeaturesofdifferentinfectivedosesoftrypanosomacruziindogsduringtheacutephase